Amendment of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 20122
1
The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 20123 are amended as follows.
2
In regulation 20 (interpretation), in paragraph (1), in the definition of—
a
“Fast Track Pathway Tool”4 for “28th November 2012” substitute “1st March 2018”;
b
“flat rate payment” for “£155.05” substitute “£158.16”;
c
“high band payment” for “£213.32” substitute “£217.59”;
d
“National Framework”5 for “28th November 2012” substitute “1st March 2018”;
e
“nursing care by a registered nurse” (which is included in the definition of “nursing care”), for “section 49(2) of the Health and Social Care Act 2001” substitute “section 22(8) of the Care Act 2014”;
f
“regulated activity” for “2010” substitute “2014”.
3
In regulation 21 (duty of relevant bodies: assessment and provision of NHS continuing healthcare)—
a
in paragraph (4)(a), for “28th November 2012” substitute “1st March 2018”6;
b
in paragraph (5)(a)(ii), for “28th November 2012” substitute “1st March 2018”7;
c
in paragraph (13), in the definition of “multi-disciplinary team”, in paragraph (b) for “persons for community care services” substitute “an adult’s needs for care and support”.
4
In Schedule 4 (services for rare and very rare conditions)—
a
after paragraph 20, insert—
20A
Alpha 1 antitrypsin services.
b
after paragraph 36, insert—
36A
Clinical genomic services.
c
after paragraph 57, insert—
57ZA
Gonadal tissue cryopreservation services for children and young people at high risk of gonadal failure due to treatment or disease.
d
after paragraph 92, insert—
92A
Psychological medicine inpatient services for severe and complex presentations of medically unexplained physical symptoms.
e
after paragraph 104, insert—
104A
Specialist adult haematology services.
f
omit paragraph 112;
g
after paragraph 140A, insert—
140AA
Termination services for expectant mothers with significant comorbidities that require either or both critical care and medical support.